Rima Al-Awar

$387,350.13asHead, Therapeutic Innovation and Drug Discovery

Employed by Ontario Institute For Cancer Research in 2024, according to Government of Ontario public salary records.

Salary Information

Historical salary and taxable benefits from 2008 to 2024.

YearPositionSalaryBenefitsPerformance
2024
Head, Therapeutic Innovation and Drug Discovery
$387,350.13
$1,231.20
16.16%
2023
Head, Therapeutic Innovation and Drug Discovery
$461,993.60
$1,462.86
5.28%
2022
Head, Therapeutic Innovation and Drug Discovery
$487,760.60
$1,375.38
5.58%
2021
Head, Therapeutic Innovation and Drug Discovery
$461,993.60
$1,244.16
14.51%
2020
Director and Senior Scientist
$540,394.38
$1,237.68
16.97%
2019
Director and Senior Scientist
$461,993.60
$1,218.24
0.16%
2018
Director and Senior Scientist
$462,746.18
$1,218.24
0.68%
2017
Director and Senior Principal Investigator
$465,906.81
$1,218.24
1.57%
2016
Director and Senior Principal Investigator
$458,691.19
$1,218.24
7.89%
2011
Director & Senior Scientist
$425,150.16
$1,010.88
2010
Director & Senior Scientist
$425,150.16
$1,093.50
1.63%
2009
Director/Senior Scientist
$418,343.38
$933.12
100.13%
2008
Director/Senior Scientist
$209,038.01
$194.40

In 2024, Rima Al-Awar received a salary of $387,350.13 working as Head, Therapeutic Innovation and Drug Discovery at Ontario Institute For Cancer Research, as disclosed on the Ontario Sunshine List. This represents a 16.16% decrease from the previous year's reported salary. Rima Al-Awar has appeared on the Ontario Sunshine List 13 times between 2008 and 2024, with reported earnings peaking at $540,394.38 in 2020. In addition to salary, $1,231.20 in taxable benefits was disclosed for 2024. Ontario Institute For Cancer Research reports under the Other Public Sector Employers sector of Ontario's public sector salary disclosure.

Top earning Head, Therapeutic Innovation and Drug Discoverys in Ontario Institute For Cancer Research

NameSalary
Rima Al-Awar$387,350.13
NameSalary
Leslie Radvanyi
President and Scientific Director
$528,461.05
Lincoln Stein
Head, Adaptive Oncology
$383,286.80
Philip Awadalla
Director and Senior Principal Investigator
$371,958.00
Christine Williams
Executive Vice President and Head, Implementation Science
$364,149.86
Peter Goodhand
Executive Lead
$321,484.80
Jeanette Dias D’Souza
Senior Vice President, Group Chief Financial Officer
$319,995.00